The approval of medicines called second-generation antipsychotics has allowed bipolar I and some conditions that come with it to be treated. A person who has bipolar I disorder can go through various ...

Aripiprazole 10mg, 15mg; vanilla flavor; contains phenylalanine. The mechanism of action of aripiprazole in the treatment of schizophrenia, bipolar I disorder, or adjunctive treatment of major ...

Aripiprazole’s new long-acting injectable (LAI) formulation enables continuous exposure to medication for two months 1. Aripiprazole once-every-two-months LAI is a new formulation containing 960 mg ...

ABILIFY MAINTENA (aripiprazole) 300mg and 400mg ext-rel injectable suspension Otsuka and Lundbeck announced that the FDA has approved Abilify Maintena (aripiprazole) for extended-release injectable ...

TOKYO — The Food and Drug Administration has approved a once-monthly treatment for schizophrenia. Otsuka Pharmaceutical and H. Lundbeck announced the FDA approval of Abilify Maintena (aripiprazole) ...

Approval provides patients with schizophrenia the ability to access the efficacy and safety profile of oral aripiprazole in a once-monthly formulation. Relapse prevention is an important consideration ...

COPENHAGEN, Nov 3 (Reuters) - H Lundbeck A/S says: ** A head-to-head study showed that patients treated with Lundbeeck's Abilify Maintena (aripiprazole once-monthly) demonstrated a statistically ...

If you have schizophrenia, your doctor may want you to take aripiprazole. That’s a prescription drug sold under the brand name Abilify. Aripiprazole is an atypical or second-generation antipsychotic ...

Aripiprazole is a generic prescription medication that’s prescribed for certain mental health conditions. Aripiprazole belongs to a class of drugs a called atypical antipsychotics. A class of drugs is ...

Aripiprazole’s new long-acting injectable (LAI) formulation enables continuous exposure to medication for two months1 Windsor, United Kingdom/Valby, Denmark, 27 March 2024 – Otsuka Pharmaceutical ...